Can Short acting Oral Contraceptives Increase Weight? Are Short acting Oral Contraceptives Disadvantaged

The first benefit: relieving premenstrual tension syndrome

Short acting oral contraceptives not only provide effective contraception, but also help women regulate their menstrual cycle, alleviate premenstrual tension syndrome, and reduce breast swelling, emotional changes, headaches, and other occurrences. In addition, it can also be used to treat acne and make the skin smoother. In addition, short-term oral contraceptives can also delay the onset of menopause in women, protect cardiovascular function, and delay physical aging.

Second benefit: effective weight control

Many women are concerned that taking short acting oral contraceptives will increase weight. The traditional short acting oral contraceptives, due to the retention of water and sodium, do make women gain weight. However, existing clinical evidence suggests that new short-term oral contraceptives can effectively control weight. Because the drospirenone component contained in it has the characteristics of salt resistant corticosteroids similar to natural progesterone, it can directly fight against water and sodium retention and promote water and sodium excretion.

Third major benefit: reducing the incidence of related tumors

Contrary to the common misconception among Chinese women, taking the new short-term oral contraceptives will not increase the risk of female reproductive system tumors and breast cancer, but also reduce the incidence of related tumors. A study by Hannaford et al. on the relationship between oral contraceptives and cancer observed and analyzed 744000 individuals who had previously or currently used oral contraceptives and 339000 individuals who had not. The results showed that compared to non users, users of oral contraceptives significantly reduced the overall incidence of cancer by 12%.

Reducing the risk of endometrial cancer: Numerous clinical studies have shown that short-term oral contraceptives can significantly reduce the risk of endometrial cancer. This is because low-dose estrogen can prevent excessive proliferation of the endometrium and reduce the probability of malignancy. Foreign studies have shown that the new generation of short acting oral contraceptives still have a protective effect on the endometrium after 1-2 years of discontinuation.

Fighting ovarian cancer: The most authoritative evidence-based medical evidence published by the Lancet in 2008 on the prevention of ovarian cancer by short-term oral contraceptives shows that ① taking short-term oral contraceptives has a long-term preventive effect on ovarian cancer; ② the longer the duration of use, the lower the risk of ovarian cancer; ③ the protective effect still exists 30 years after discontinuation of medication.

It has nothing to do with the prevalence of breast cancer: in fact, the incidence of breast cancer is closely related to race, genetics, smoking, age and other factors. A large number of surveys conducted in the United Kingdom, the United States and Canada since 2002 have shown that women who use long-term and conventional short acting oral contraceptives do not significantly increase the risk of breast cancer.